Man Group’s QuidelOrtho QDEL Stock Holding History

Man Group’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-200	Closed	-$26K	–	2062
2021 Q2	$26K	Buy	+200	New	+$23.5K	﹤0.01%	1907

Other funds holding QDEL

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Man Group's QDEL Position: Q3 2025 in Review

Man Group sold out of QuidelOrtho (QDEL) in Q3 2025, closing a stake of 9,300 shares — an estimated $268K sold.

Man Group first reported a position in QDEL in Q2 2018 and held it in 24 quarters. The position peaked at $24.6M in Q1 2022. 254 funds tracked by Wall St. Rank hold QDEL as of Q3 2025.

Man Group reported no remaining QuidelOrtho position as of Q3 2025 after selling out during the quarter.
Man Group sold 9,300 QuidelOrtho shares in Q3 2025, an estimated $268K.
Man Group first reported a position in QuidelOrtho in Q2 2018 and held it in 24 quarters.
Man Group's QuidelOrtho position peaked at $24.6M in Q1 2022.
254 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2025.

Based on Man Group's 13F filing for Q3 2025, filed 14 Nov 2025.